These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 381915)

  • 1. Cytogenetic effects of diethylstilbestrol-diphosphate (DES-dp) on mouse bone marrow monitored by the micronucleus test.
    Chrisman CL; Baumgartner AP
    Mutat Res; 1979 Jun; 67(2):157-60. PubMed ID: 381915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate.
    Schneider MR; von Angerer E; Prekajac J; Brade WP
    J Cancer Res Clin Oncol; 1986; 111(2):110-4. PubMed ID: 3754557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplacental mutagenesis: the micronucleus test on fetal mouse blood.
    King MT; Wild D
    Hum Genet; 1979 Oct; 51(2):183-94. PubMed ID: 574495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichloroacetic acid: investigation into the mechanism of chromosomal damage in the in vitro human lymphocyte cytogenetic assay and the mouse bone marrow micronucleus test.
    Mackay JM; Fox V; Griffiths K; Fox DA; Howard CA; Coutts C; Wyatt I; Styles JA
    Carcinogenesis; 1995 May; 16(5):1127-33. PubMed ID: 7767975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of sixteen carcinogens in the rat using the micronucleus test.
    Trzos RJ; Petzold GL; Brunden MN; Swenberg JA
    Mutat Res; 1978 Sep; 58(1):79-86. PubMed ID: 362195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4CMB: investigation of activity in a mouse micronucleus test.
    Whalley HE; Bootman J; Rees R
    Mutat Res; 1982; 100(1-4):361-4. PubMed ID: 7057773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The micronucleus test with mouse spleen cells.
    Shindo Y; Hirano F; Maeda H; Takeda U
    Mutat Res; 1983 Jul; 121(1):53-7. PubMed ID: 6408474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of a multiple dosing protocol for the mouse bone-marrow micronucleus assay using benzidine and 2,6-xylidine.
    Parton JW; Beyers JE; Garriott ML; Tamura RN
    Mutat Res; 1990; 234(3-4):165-8. PubMed ID: 2366785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the clastogenic effect of cyclophosphamide by WR-2721 in the bone marrow of mice.
    Mazur L; Czyzewska A
    Mutat Res; 1994 Sep; 309(2):219-23. PubMed ID: 7520979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between experimental results in mammals and man. I. Cytogenetic analysis of bone marrow injury induced by a single dose of cyclophosphamide.
    Goetz R; Srám RJ; Dohnalová J
    Mutat Res; 1975 Aug; 31(4):247-54. PubMed ID: 1143298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clastogen-induced micronuclei in peripheral blood erythrocytes: the basis of an improved micronucleus test.
    MacGregor JT; Wehr CM; Gould DH
    Environ Mutagen; 1980; 2(4):509-14. PubMed ID: 6796407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the mutagenic potential of 2-(2',4'-diaminophenoxy)ethanol using the micronucleus test.
    Richardson JC; Richold M
    Mutat Res; 1982 Dec; 102(4):357-60. PubMed ID: 7177149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single and multiple treatment regimens in the mouse bone marrow micronucleus assay for hydroquinone (HQ) and cyclophosphamide (CP).
    Adler ID; Kliesch U
    Mutat Res; 1990; 234(3-4):115-23. PubMed ID: 2366778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytogenetic approach to evaluate in vivo somatic aneuploidy. Effects of diethylstilboestrol on mouse bone marrow cells.
    Zijno A; Quaggia S; Pacchierotti F
    Mutagenesis; 1989 Jan; 4(1):62-6. PubMed ID: 2654554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micronucleus test and bone-marrow chromosome analysis: a comparison of 2 methods in vivo for evaluating chemically induced chromosomal alterations.
    Kliesch U; Danford N; Adler ID
    Mutat Res; 1981 Feb; 80(2):321-32. PubMed ID: 7207488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two methods for evaluating drug-induced chromosome alterations.
    Frank DW; Trzos RJ; Good PI
    Mutat Res; 1978 Jan; 56(3):311-7. PubMed ID: 342948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of diisopropylcarbodiimide (Cas No. 693-13-0) in F344/N rats and B6C3F1 mice (dermal studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2007 Feb; (523):1-286. PubMed ID: 17554397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential estrogenic and antiestrogenic activity of the cyclic siloxane octamethylcyclotetrasiloxane (D4) and the linear siloxane hexamethyldisiloxane (HMDS) in immature rats using the uterotrophic assay.
    McKim JM; Wilga PC; Breslin WJ; Plotzke KP; Gallavan RH; Meeks RG
    Toxicol Sci; 2001 Sep; 63(1):37-46. PubMed ID: 11509742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micronucleus test with cyclophosphamide using mouse peripheral blood reticulocytes.
    Hatanaka Y; Kitagawa Y; Toyoda Y; Kawata T; Ando N; Kawabata Y; Iwai M; Arimura H
    Mutat Res; 1992; 278(2-3):99-101. PubMed ID: 1372710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specificity of pyrimethamine in the rodent bone marrow micronucleus test.
    Ono T; Sekiya T; Takahashi Y; Sasaki YF; Ohta T
    Mutat Res; 1997 Apr; 390(1-2):167-70. PubMed ID: 9150765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.